Matthew W Towse - SVP and Chief Financial Office, Nxstage Medical, Inc
As of January 11, 2016
What is Matthew W Towse's Net Worth?
The current estimated net worth of Nxstage Medical, Inc's SVP and Chief Financial Office, Matthew W Towse, is estimated to be about $2M . Matthew W Towse owns about 12,947 units of Nxstage Medical, Inc common stock. In the last 3 years at Nxstage Medical, Inc, Matthew W Towse has sold an estimated value of $214.41K worth.
What is Matthew W Towse's Past Insider Trading?
Matthew W Towse's largest purchase order was 3,472 units , worth over $48.78K on January 11, 2016. Matthew W Towse's largest sale order was 5,455 units , worth over $84.66K on August 10, 2015. In total, Matthew W Towse has made about 6 transactions over 3 years of their time at Nxstage Medical, Inc. Matthew W Towse usually trades in July, with the busiest year in 2015 and 2014.
Matthew Towse
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are Nxstage Medical, Inc's Past Insider Trades?
Nxstage Medical, Inc's most recent insider trade came on February 22, 2018 by Winifred Swan who sold 3,500 units worth $85.68K . In the last 13 years, insiders at Nxstage Medical, Inc have sold an estimated value of $404.73M and bought an estimated value of $77.15M worth of shares. Insider trading is most common in March, with the busiest year in 2011. The most active traders at the company are Joseph Turk, President, Winifred Swan, SVP and General Counsel, and Jeffrey Burbank, Chief Executive Officer .
NxStage Medical, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||